Surgery for Barrett’s esophagus shows a significant regression rate, particularly in shorter segments, influencing patient management. Histologic regression occurred in 53.4% of patients overall, with 68.9% in ultrashort and 51.2% in short segments, but 0% in long-segment Barrett’s (p<0.001). Key predictors of regression included an anatomically intact repair (64.2% vs. 38.8% for disrupted, p<0.001) and […]
Category: Upper Gastrointestinal Tract
High hospital volume lowers mortality in esophageal and gastric surgery
Higher hospital surgical volume leads to significantly better outcomes for esophagectomy and gastrectomy patients. 30-day mortality drops to 51% lower (odds ratio 0.51) at high-volume hospitals performing 4-239 resections/year. 90-day mortality reduced by 35% (odds ratio 0.65) and fewer complications observed (odds ratio 0.83). Surgical teams should consider hospital volume when planning procedures. Optimal volume […]
Minimally Invasive Surgery Improves Outcomes in Esophageal Cancer
Conversion minimally invasive esophagectomy is a viable option for cT4b esophageal cancer patients previously deemed unresectable, offering significant benefits. Patients undergoing conversion minimally invasive esophagectomy (c-mie) experienced less intraoperative blood loss (79 ml vs. 470 ml, p < 0.001) and a lower risk of anastomotic leakage (4.8% vs. 24%, p = 0.04). ICU stays were […]
Fluorescence Lymphography in Esophagectomy Shows No Chyle Leakage Benefit
New study evaluates indocyanine green fluorescence to prevent chyle leakage during esophagectomy, but results are mixed. Chyle leakage incidence: 17% in the ICG group vs. 10% in controls (p = 0.163). ICG influenced intraoperative decisions in 36% of cases, with successful thoracic duct visualization in 85%. Surgeons may not see a reduction in chyle leakage, […]
Gastric Cancer Peritoneal Metastasis Management Consensus Established
New guidelines for managing gastric cancer peritoneal metastasis (gcpm) offer surgeons a pathway to improve patient outcomes. Experts developed 13 consensus statements on diagnosis and treatment, with 75-100% agreement among a global panel. A broader survey yielded 12 out of 13 consensus among 63 experts, but only 52% agreed on systemic treatment best practices. This […]
Survival Advantage with Neoadjuvant Chemotherapy in Oscc
For patients with resectable oesophageal squamous cell carcinoma, neoadjuvant chemotherapy offers significantly better survival outcomes than chemoradiotherapy after achieving a pathological complete response. Among patients achieving complete response, 5-year overall survival was 97.5% with chemotherapy vs. 70.4% with chemoradiotherapy. Recurrence-free survival also favored chemotherapy (80.8% vs. 63.7%). Consideration of watch-and-wait strategies may be warranted for […]
Age-Dependent Outcomes in Gastrectomy Reconstruction Choices
Choosing between tubular esophagogastric and double-tract anastomosis for older patients can affect perioperative safety and long-term quality of life. Patients aged 70+ had fewer complications with tubular esophagogastric (25.9% vs. 50.0% for double-tract, p=0.049). Double-tract anastomosis had longer operative times (232.1 min vs. 217.6 min for tubular esophagogastric, p=0.016) and better reflux control at 12 […]
Long-term Outcomes of Laparoscopic Nissen Fundoplication
Nissen fundoplication yields lasting relief for GERD, with high satisfaction rates over a decade or more. Heartburn decreased from 94.2% to 33.7%, regurgitation from 68.7% to 13.4%, and esophagitis from 61.7% to 7.4%. Only 17% experienced symptom recurrence, while 87% reported they would choose the procedure again. Postoperative challenges include gas-bloating (53%) and dysphagia (26%), […]
Pyloroplasty reduces complications in minimally invasive esophagectomy
Adding pyloroplasty during esophagectomy significantly lowers the risk of short-term complications. Patients undergoing pyloroplasty had a pneumonia or anastomotic leak rate of 18% compared to 27% in those without the procedure. The trial led to early stopping when superiority of pyloroplasty was confirmed with a 90% probability. Surgeons can confidently incorporate pyloroplasty to enhance patient […]
Postoperative complications don’t impact survival after esophagectomy for cancer.
In a study of 541 patients with esophageal cancer undergoing neoadjuvant therapy, complications like pneumonia and anastomotic leakage showed no significant effect on overall survival across treatment arms. The shift from open to thoracoscopic esophagectomy reduced the prognostic impact of complications, with hazard ratios for overall survival decreasing significantly. Minimally invasive techniques may enhance patient […]
